A detailed history of Curbstone Financial Management Corp transactions in Amgen Inc stock. As of the latest transaction made, Curbstone Financial Management Corp holds 1,912 shares of AMGN stock, worth $542,262. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,912
Previous 1,912 -0.0%
Holding current value
$542,262
Previous $597,000 3.18%
% of portfolio
0.13%
Previous 0.13%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 03, 2024

SELL
$262.75 - $319.31 $13,137 - $15,965
-50 Reduced 2.55%
1,912 $597,000
Q1 2024

Apr 09, 2024

SELL
$268.87 - $324.56 $13,443 - $16,228
-50 Reduced 2.49%
1,962 $557,000
Q3 2022

Oct 05, 2022

BUY
$224.46 - $253.15 $11,671 - $13,163
52 Added 2.65%
2,012 $454,000
Q1 2022

Apr 18, 2022

SELL
$219.27 - $242.57 $26,312 - $29,108
-120 Reduced 5.77%
1,960 $474,000
Q3 2021

Oct 06, 2021

SELL
$212.27 - $248.7 $21,227 - $24,870
-100 Reduced 4.59%
2,080 $442,000
Q2 2021

Jul 09, 2021

SELL
$233.58 - $259.14 $23,358 - $25,914
-100 Reduced 4.39%
2,180 $531,000
Q3 2020

Oct 02, 2020

SELL
$234.65 - $260.95 $44,583 - $49,580
-190 Reduced 7.69%
2,280 $579,000
Q2 2020

Jul 10, 2020

SELL
$197.81 - $242.74 $39,562 - $48,548
-200 Reduced 7.49%
2,470 $583,000
Q3 2019

Oct 18, 2019

SELL
$174.11 - $208.62 $3,482 - $4,172
-20 Reduced 0.74%
2,670 $517,000
Q2 2019

Jul 09, 2019

SELL
$166.7 - $195.41 $5,001 - $5,862
-30 Reduced 1.1%
2,690 $496,000
Q1 2019

Apr 10, 2019

SELL
$180.87 - $203.88 $9,043 - $10,194
-50 Reduced 1.81%
2,720 $517,000
Q1 2018

Apr 10, 2018

BUY
$169.43 - $198.0 $234,660 - $274,230
1,385 Added 100.0%
2,770 $472,000
Q4 2017

Jan 08, 2018

SELL
$168.79 - $188.59 $299,264 - $334,370
-1,773 Reduced 56.14%
1,385 $241,000
Q3 2017

Oct 03, 2017

BUY
$167.29 - $191.0 $528,301 - $603,178
3,158
3,158 $589,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Curbstone Financial Management Corp Portfolio

Follow Curbstone Financial Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Curbstone Financial Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Curbstone Financial Management Corp with notifications on news.